Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial-Reference-Cited by-同舟云学术

Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial

Published:2014-12-23 Issue:6 Volume:60 Page:1724-1732
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Kim Eun Hye,Lee Yong Chan,Chang Young Woon,Park Jong-Jae,Chun Hoon Jai,Jung Hwoon-Yong,Kim Hyun-Soo,Jeong Hyun Yong,Seol Sang-Young,Han Sok Won,Choi Myung-Gyu,Park Soo-Heon,Lee Ok-Jae,Jung Jin Tae,Lee Dong Ho,Jung Hyun Chae,Lee Soo Teik,Kim Jae Gyu,Youn Sei Jin,Kim Hak Yang,Lee Sang Woo

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-014-3489-4.pdf

Reference26 articles.

1. Cho YS, Choi MG, Jeong JJ, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol. 2005;100:747–753.

2. Bai Y, Du Y, Zou D, et al. Gastroesophageal reflux disease questionnaire (GerdQ) in real-world practice: a national multicenter survey on 8065 patients. J Gastroenterol Hepatol. 2013;28:626–631.

3. Cho YK, Kim GH, Kim JH, et al. Diagnosis of gastroesophageal reflux disease: a systematic review. Korean J Gastroenterol. 2010;55:279–295.

4. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol. 2006;4:398–407.

5. Khan M, Santana J, Donnellan C, et al. Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev. 2007;18:CD003244.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features and therapeutic responses to proton pump inhibitor in patients with severe reflux esophagitis: A multicenter prospective observational study;JGH Open;2020-12-08

2. Vonoprazan versus proton‐pump inhibitors for healing gastroesophageal reflux disease: A systematic review;Journal of Gastroenterology and Hepatology;2019-04-11

3. Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease;Digestive Diseases and Sciences;2017-11-06

4. Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin;European Journal of Clinical Pharmacology;2017-10-06

5. Pharmacokinetic Properties of Oral Lafutidine Tablets and the Effect of Food on its Pharmacokinetics in Healthy Chinese Subjects;Advances in Therapy;2016-07-21